← Back to all trials
Enrolling By Invitation
NCT07665502
Pre-Pilot WINGS+++: mHealth to Improve MOUD Uptake in Women Experiencing Intimate Partner Violence and PTSD
Conditions: Opioid-Related Disorders, Substance-Related Disorders, Intimate Partner Violence (IPV), Stress Disorders, Post-Traumatic, Domestic Violence, Medication for Opioid Use Disorder (MOUD), Post Traumatic Stress Disorder PTSD
Sex: Female
Ages: 18 Years – N/A
Healthy volunteers: No
Phase: NA
Enrollment: 7
Sponsor: Dawn A. Goddard-Eckrich
Location: Columbia University School of Social Work New York New York
Summary
The goal of this pre-pilot for the clinical trial is to develop a mobile health (mHealth) program called WINGS+++ can help women with opioid use disorder or other substance use disorders who have experienced intimate partner violence. The pre-pilot study will take place in Orange County, New York with n=7 women. .
The main questions it aims to answer are:
1. Does WINGS+++ lower non-prescription opioid and other drug use in women?
2. Does WINGS+++ help connect women to treatment for substance use, intimate partner violence, and post-traumatic stress disorder (PTSD)?
Researchers will compare WINGS+++ to standard care to see if WINGS+++ works better to lower drug use and link women to helpful services.
WINGS+++ is a 3-session program on a mobile device that:
* Screens for intimate partner violence, PTSD, and substance use
* Offers brief support and referrals based on each woman's needs and preferences
* Connects women to a peer navigator who helps link them to services
Participants will:
* Take part in only the WINGS+++ program for the pre-pilot
* Answer survey questions about drug use, intimate partner violence, and PTSD symptoms
* Provide biological samples (such as urine or hair) to check for drug use
* Share information about the services they have used
Eligibility Criteria
Inclusion Criteria:
* Identify as a woman (cis-gender or transgender)
* Aged 18 or older
* Report use of non-prescribed opioids in the past 30 days
* Score positive for risk of opioid use disorder or other substance use disorder on the Drug Abuse Screening Test (DAST) with a cut-off score of 6 or higher
* Report experiencing any severe psychological abuse or any physical or sexual abuse by a female or male intimate partner in the past year
Exclusion Criteria:
* Evidence of significant psychiatric or cognitive impairment that would limit effective participation, as confirmed during informed consent
* Inability to speak and understand English sufficiently to participate in assessments or intervention sessions
Source: ClinicalTrials.gov (NCT07665502). StuddyBuddy aggregates publicly available trial information.